×

Isamu Tachibana, M.D.

Urology
Testicular Cancer
Kidney Cancer

New Patient Appointment Accepting Virtual Visits or 214-645-8765

New Patient Appointment or 214-645-8765

See Dr. Tachibana's Locations

Biography

Isamu Tachibana, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center. He specializes in urologic malignancies including bladder, kidney, prostate, adrenal, penile, and testicular cancer.

Dr. Tachibana grew up in Texas and earned his medical degree at UT Southwestern Medical School. He completed a urology residency and urologic oncology fellowship at Indiana University Hospital, where he received advanced training in complex oncologic procedures including retroperitoneal lymph node dissection, procedures for locally advanced kidney cancer, and various urinary diversions such as continent urinary reservoirs (Indiana Pouch) and neobladders.

He joined the UT Southwestern faculty in 2023.

Dr. Tachibana is a member of the American Urological Association and the Society of Urologic Oncology.

His research interests include the treatment of testicular cancer. He has published research in a variety of medical journals, including the Journal of Clinical Oncology, European Urology, Journal of Urology, and Urologic Oncology. He also serves as a reviewer for these journals.

Personal Note

Dr. Tachibana’s interests outside of medicine include hiking, playing tennis, and spending time with family.

Education & Training

Fellowship - Indiana University School of Medicine (2021-2023), Urologic Oncology
Residency - Indiana University School of Medicine (2016-2021), Urology
Medical School - UT Southwestern Medical Center School of Health Professions (2012-2016)

Professional Associations & Affiliations

American Urological Association
Society of Urologic Oncology

Honors & Awards

Best Poster 2023, American Urological Association
Alpha Omega Alpha Honor Medical Society 2016, UT Southwestern Medical School

Books & Publications

Publications
- Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy.
  Tachibana I, Alabd A, Whaley RD, McFadden J, Piroozi A, Hassoun R, Kern SQ, King J, Adra N, Rice KR, Foster RS, Einhorn LH, Cary C, Masterson TA, Urologic oncology 2023 Aug
- Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
  Tachibana I, Alabd A, Tong Y, Piroozi A, Mahmoud M, Kern SQ, Masterson TA, Adra N, Foster RS, Hanna NH, Einhorn LH, Cary C, Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Aug 41 23 3930-3938
- Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
  Tachibana I, Kern SQ, Douglawi A, Tong Y, Mahmoud M, Masterson TA, Adra N, Foster RS, Einhorn LH, Cary C, Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 Nov 40 32 3762-3769
- Delaying Cancer Cases in Urology during COVID-19: Review of the Literature.
  Tachibana I, Ferguson EL, Mahenthiran A, Natarajan JP, Masterson TA, Bahler CD, Sundaram CP, The Journal of urology 2020 Nov 204 5 926-933
- Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
  Douglawi A, Calaway A, Tachibana I, Panizzutti Barboza M, Speir R, Masterson T, Adra N, Foster R, Einhorn L, Cary C, The Journal of urology 2020 Jul 204 1 96-103
- Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.
  Calaway AC, Tachibana I, Masterson TA, Foster RS, Einhorn LH, Cary C, Urology 2019 May 127 74-79

Research

Biomarkers and novel imaging with testicular cancer
Clinical trials for bladder, kidney, and testicular cancer

Clinical Focus

Testicular Cancer
Kidney Cancer
Bladder Cancer

New Patient Appointment Accepting Virtual Visits or 214-645-8765